Yi Ge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yi Ge has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Syed Mahmood
Department of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur 50603, Malaysia
8 shared publications - Zarif Mohamed Sofian
Department of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, Malaysia
5 shared publications - Ramsha Khalid
Department of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur 50603, Malaysia
4 shared publications - Peifeng Li
School of Pharmacy, Queen’s University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK
3 shared publications - Saeid Mezail Mawazi
Management and Science University, Shah Alam, Malaysia, Malaysia
3 shared publications - Siqi Wang
School of Pharmacy, Queen’s University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK
3 shared publications
Latest Publications
- Open Access
Simulation-Guided Design and Synthesis of Functionalized Lactose-Crosslinked Degradable Molecularly Imprinted Polymer Nanoparticles for Sialic Acid Recognition
Aberrant cell-surface sialylation is widely associated with cancer progression and provides an accessible molecular feature for biosensing and targeted delivery. However, engineering molecularly imprinted polymer nanoparticles (nanoMIPs) that combine selective sialic acid (SA) recognition with controlled degradability and cytocompatibility remains challenging. In this study, a simulation-guided strategy was used to develop hydrolytically degradable SA-imprinted nanoMIPs incorporating a functionalized lactose-based crosslinker with cleavable ester linkages. Molecular docking and quantum-chemical calculations identified N-isopropylacrylamide (NIPAM), acrylamide (AAm), and N-hydroxyethyl acrylamide (HEAA) as complementary functional monomers and established an optimized SA:NIPAM:AAm:HEAA molar ratio of 1:1:2:1. The resulting nanoMIPs were spherical and nanoscale and exhibited pH-dependent hydrolytic mass loss that was more pronounced under mildly acidic conditions than at physiological pH. Compared with non-imprinted nanoparticles, the nanoMIPs displayed substantially enhanced SA binding, with a maximum binding capacity of 89.38 μmol g−1 and an imprinting factor of approximately 4.2, together with preferential recognition of SA over the selected competing molecules. MTT assays using MCF-7, HeLa, and HaCaT cells showed cell viability above 80% after 24 h exposure to 500 μg mL−1, indicating favorable short-term cytocompatibility. By integrating computationally optimized, multicomponent SA recognition with a carbohydrate-derived, hydrolytically degradable crosslinking strategy, this work addresses the coupled requirements of binding-site fidelity and material degradability within a single nanoMIP platform. These findings establish a materials-level foundation for future SA-directed biosensing and targeted delivery systems in cancer-relevant applications.
Open AccessSimulation-Guided Design and Synthesis of Functionalized Lactose-Crosslinked Degradable Molecularly Imprinted Polymer Nanoparticles for Sialic Acid Recognition
Aberrant cell-surface sialylation is widely associated with cancer progression and provides an accessible molecular feature for biosensing and targeted delivery. However, engineering molecularly imprinted polymer nanoparticles (nanoMIPs) that combine selective sialic acid (SA) recognition with controlled degradability and cytocompatibility remains challenging. In this study, a simulation-guided strategy was used to develop hydrolytically degradable SA-imprinted nanoMIPs incorporating a functionalized lactose-based crosslinker with cleavable ester linkages. Molecular docking and quantum-chemical calculations identified N-isopropylacrylamide (NIPAM), acrylamide (AAm), and N-hydroxyethyl acrylamide (HEAA) as complementary functional monomers and established an optimized SA:NIPAM:AAm:HEAA molar ratio of 1:1:2:1. The resulting nanoMIPs were spherical and nanoscale and exhibited pH-dependent hydrolytic mass loss that was more pronounced under mildly acidic conditions than at physiological pH. Compared with non-imprinted nanoparticles, the nanoMIPs displayed substantially enhanced SA binding, with a maximum binding capacity of 89.38 μmol g−1 and an imprinting factor of approximately 4.2, together with preferential recognition of SA over the selected competing molecules. MTT assays using MCF-7, HeLa, and HaCaT cells showed cell viability above 80% after 24 h exposure to 500 μg mL−1, indicating favorable short-term cytocompatibility. By integrating computationally optimized, multicomponent SA recognition with a carbohydrate-derived, hydrolytically degradable crosslinking strategy, this work addresses the coupled requirements of binding-site fidelity and material degradability within a single nanoMIP platform. These findings establish a materials-level foundation for future SA-directed biosensing and targeted delivery systems in cancer-relevant applications.
- Open Access
- 15 April 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (4) , 487
Carbon Dots and Their Functionalization with Photosensitizer Chlorin E6: Advancing Antibacterial Efficacy Through Enhanced Photodynamic Effects
Background/Objectives: Carbon dots (CDs) are promising antimicrobial nanomaterials owing to their biocompatibility, environmental friendliness, and tunable surface chemistry. This study aimed to synthesize nitrogen-doped CDs (AS-CDs) and develop a light-responsive antibacterial system through conjugation with chlorin e6 (Ce6). Methods: AS-CDs were synthesized by a microwave-assisted method using L-ascorbic acid and spermidine, followed by conjugation with Ce6. The materials were characterized by transmission electron microscopy, zeta potential analysis, and spectroscopic methods, and their antibacterial activity was evaluated against Escherichia coli, Staphylococcus aureus, and methicillin-resistant S. aureus (MRSA) under both dark and visible-light conditions. Cytotoxicity was assessed using HaCaT cells. Results: The AS-CDs exhibited a uniform nanoscale morphology with an average diameter of 6.3 nm and a positive surface charge of +15.6 mV, together with intrinsic broad-spectrum antibacterial activity. Ce6 conjugation further enhanced antibacterial efficacy under light irradiation, with the CDs-Ce6 conjugate achieving complete eradication of S. aureus and MRSA and marked inhibition of E. coli at 2.5 μg/mL. Cytotoxicity studies demonstrated low toxicity in HaCaT cells within the effective antibacterial concentration range. Conclusions: These findings highlight the potential of microwave-synthesized, photosensitizer-conjugated CDs as next-generation antimicrobial agents. This platform offers a cost-effective, sustainable, eco-friendly, and efficient platform for combating bacterial infections, with broader potential in pharmaceutical and biomedical applications.
- 15 April 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (4) , 487
Open AccessCarbon Dots and Their Functionalization with Photosensitizer Chlorin E6: Advancing Antibacterial Efficacy Through Enhanced Photodynamic Effects
Background/Objectives: Carbon dots (CDs) are promising antimicrobial nanomaterials owing to their biocompatibility, environmental friendliness, and tunable surface chemistry. This study aimed to synthesize nitrogen-doped CDs (AS-CDs) and develop a light-responsive antibacterial system through conjugation with chlorin e6 (Ce6). Methods: AS-CDs were synthesized by a microwave-assisted method using L-ascorbic acid and spermidine, followed by conjugation with Ce6. The materials were characterized by transmission electron microscopy, zeta potential analysis, and spectroscopic methods, and their antibacterial activity was evaluated against Escherichia coli, Staphylococcus aureus, and methicillin-resistant S. aureus (MRSA) under both dark and visible-light conditions. Cytotoxicity was assessed using HaCaT cells. Results: The AS-CDs exhibited a uniform nanoscale morphology with an average diameter of 6.3 nm and a positive surface charge of +15.6 mV, together with intrinsic broad-spectrum antibacterial activity. Ce6 conjugation further enhanced antibacterial efficacy under light irradiation, with the CDs-Ce6 conjugate achieving complete eradication of S. aureus and MRSA and marked inhibition of E. coli at 2.5 μg/mL. Cytotoxicity studies demonstrated low toxicity in HaCaT cells within the effective antibacterial concentration range. Conclusions: These findings highlight the potential of microwave-synthesized, photosensitizer-conjugated CDs as next-generation antimicrobial agents. This platform offers a cost-effective, sustainable, eco-friendly, and efficient platform for combating bacterial infections, with broader potential in pharmaceutical and biomedical applications.
- Open Access
- 20 October 2025
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 20 (6) , 1-22
Rapid Dissolvable Microneedles Integrated with Felodipine-Loaded Liposome: Fabrication, Characterizations, in-vitro and ex-vivo Evaluation
- 20 October 2025
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 20 (6) , 1-22
Open AccessRapid Dissolvable Microneedles Integrated with Felodipine-Loaded Liposome: Fabrication, Characterizations, in-vitro and ex-vivo Evaluation
- Open Access
- 28 August 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (9) , 1288
A Systematic Review of Advances in Plant-Based Phospholipid Liposomes in Breast Cancer Therapy: Characterization, Innovations, Clinical Applications, and Future Directions
Introduction: Plant-based phospholipid (PP) liposomes are sustainable, biocompatible, and biodegradable carriers with advantages over synthetic and animal-derived lipids, including lower immunogenic risk and abundant availability from sources such as soy, sunflower, and canola. This systematic review examines their characteristics, innovations, and applications in breast cancer (BCA) therapy. Methods: A total of 43 studies published between 2010 and June 2025 were identified from MEDLINE, Scopus, and Web of Science, focusing on PP composition, drug delivery mechanisms, and therapeutic efficacy in in vitro, in vivo, and preclinical BCA models. Results: Advances include nanotechnology and ligand-targeted systems that improve stability, control drug release, and enhance tumor-specific uptake. PP liposomes co-loaded with chemotherapeutics showed synergistic anticancer effects, increased tumor accumulation, and reduced systemic toxicity. Personalized targeting strategies further improved therapeutic precision and minimized off-target effects. Conclusions: PP liposomes offer an innovative and environmentally sustainable approach for BCA treatment with demonstrated preclinical benefits in efficacy and safety. Translation to clinical practice requires standardized characterization, scalable production, and well-designed trials to confirm safety, dosing, and long-term effectiveness.
- 28 August 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (9) , 1288
Open AccessA Systematic Review of Advances in Plant-Based Phospholipid Liposomes in Breast Cancer Therapy: Characterization, Innovations, Clinical Applications, and Future Directions
Introduction: Plant-based phospholipid (PP) liposomes are sustainable, biocompatible, and biodegradable carriers with advantages over synthetic and animal-derived lipids, including lower immunogenic risk and abundant availability from sources such as soy, sunflower, and canola. This systematic review examines their characteristics, innovations, and applications in breast cancer (BCA) therapy. Methods: A total of 43 studies published between 2010 and June 2025 were identified from MEDLINE, Scopus, and Web of Science, focusing on PP composition, drug delivery mechanisms, and therapeutic efficacy in in vitro, in vivo, and preclinical BCA models. Results: Advances include nanotechnology and ligand-targeted systems that improve stability, control drug release, and enhance tumor-specific uptake. PP liposomes co-loaded with chemotherapeutics showed synergistic anticancer effects, increased tumor accumulation, and reduced systemic toxicity. Personalized targeting strategies further improved therapeutic precision and minimized off-target effects. Conclusions: PP liposomes offer an innovative and environmentally sustainable approach for BCA treatment with demonstrated preclinical benefits in efficacy and safety. Translation to clinical practice requires standardized characterization, scalable production, and well-designed trials to confirm safety, dosing, and long-term effectiveness.
- Open Access
- 31 July 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (8)
Correction: Khalid et al. Development of Rapidly Dissolving Microneedles Integrated with Valsartan-Loaded Nanoliposomes for Transdermal Drug Delivery: In Vitro and Ex Vivo Evaluation. Pharmaceutics 2025, 17, 483
In the original publication [...].
- 31 July 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (8)
Open AccessCorrection: Khalid et al. Development of Rapidly Dissolving Microneedles Integrated with Valsartan-Loaded Nanoliposomes for Transdermal Drug Delivery: In Vitro and Ex Vivo Evaluation. Pharmaceutics 2025, 17, 483
In the original publication [...].
- Open Access
- 31 July 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (8) , 996
Inhalable Nanomaterial Discoveries for Lung Cancer Therapy: A Review
Lung cancer remains one of the most common and deadliest forms of cancer worldwide despite notable advancements in its management. Conventional treatments, such as chemotherapy, often have limitations in effectively targeting cancer cells, which frequently lead to off-target side effects. In this context, the pulmonary delivery of inhalable nanomaterials offers the advantages of being rapid, efficient, and target-specific, with minimal systemic side effects. This concise review summarizes the basic research and clinical translation of inhalable nanomaterials for the treatment of lung cancer. We also provide insights into the latest advances in pulmonary drug delivery systems, focusing on various types of pulmonary devices and nanomaterials. Furthermore, this paper discusses significant challenges in translating the discoveries of inhalable nanomaterials into clinical care for lung cancer and shares strategies to overcome these issues.
- 31 July 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (8) , 996
Open AccessInhalable Nanomaterial Discoveries for Lung Cancer Therapy: A Review
Lung cancer remains one of the most common and deadliest forms of cancer worldwide despite notable advancements in its management. Conventional treatments, such as chemotherapy, often have limitations in effectively targeting cancer cells, which frequently lead to off-target side effects. In this context, the pulmonary delivery of inhalable nanomaterials offers the advantages of being rapid, efficient, and target-specific, with minimal systemic side effects. This concise review summarizes the basic research and clinical translation of inhalable nanomaterials for the treatment of lung cancer. We also provide insights into the latest advances in pulmonary drug delivery systems, focusing on various types of pulmonary devices and nanomaterials. Furthermore, this paper discusses significant challenges in translating the discoveries of inhalable nanomaterials into clinical care for lung cancer and shares strategies to overcome these issues.
- Open Access
- 24 June 2025
- Published by Polish Pharmaceutical Society in Acta Poloniae Pharmaceutica - Drug Research
- Vol. 82 (1) , 101-115
Formulation of a Positively Charged Testosterone Niosome-Loaded Hydrogel: Optimization, IVIVC Correlation, and pharmacokinetic evaluation
The present study deals with the formulation of a hydrogel based on the positively charged niosomes for the delivery of testosterone at an improved skin permeation rate and offering sustained release. Testosterone-loaded niosomes (F1, F2, F3) were prepared with different concentrations of an octadecyl amine as a positive charge inducer combined with Span 60, Tween 60, and cholesterol; subsequently, these were incorporated into a hydrogel matrix of xanthan gum, iota carrageenan, and hyaluronic acid. Characterization confirmed stability, encapsulation efficiency, and diffusion-controlled drug release for each formulation. In vitro, ex vivo, and in vivo pharmacokinetic studies demonstrated that formulation H3, with the highest concentration of octadecyl amine, achieved maximum release and systemic absorption compared to H1, H2, and the marketed Androgel reference. Strong IVIVC correlation supports the potential of niosome-based hydrogel for the transdermal delivery of testosterone and that HF provided an optimized and sustained release of the hormone for clinical applications in hormone replacement therapy.
- 24 June 2025
- Published by Polish Pharmaceutical Society in Acta Poloniae Pharmaceutica - Drug Research
- Vol. 82 (1) , 101-115
Open AccessFormulation of a Positively Charged Testosterone Niosome-Loaded Hydrogel: Optimization, IVIVC Correlation, and pharmacokinetic evaluation
The present study deals with the formulation of a hydrogel based on the positively charged niosomes for the delivery of testosterone at an improved skin permeation rate and offering sustained release. Testosterone-loaded niosomes (F1, F2, F3) were prepared with different concentrations of an octadecyl amine as a positive charge inducer combined with Span 60, Tween 60, and cholesterol; subsequently, these were incorporated into a hydrogel matrix of xanthan gum, iota carrageenan, and hyaluronic acid. Characterization confirmed stability, encapsulation efficiency, and diffusion-controlled drug release for each formulation. In vitro, ex vivo, and in vivo pharmacokinetic studies demonstrated that formulation H3, with the highest concentration of octadecyl amine, achieved maximum release and systemic absorption compared to H1, H2, and the marketed Androgel reference. Strong IVIVC correlation supports the potential of niosome-based hydrogel for the transdermal delivery of testosterone and that HF provided an optimized and sustained release of the hormone for clinical applications in hormone replacement therapy.
- Open Access
- 7 April 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (4) , 483
Development of Rapidly Dissolving Microneedles Integrated with Valsartan-Loaded Nanoliposomes for Transdermal Drug Delivery: In Vitro and Ex Vivo Evaluation
Background: Hypertension (HTN) is recognized as a major risk factor for cardiovascular disease, chronic kidney disease, and peripheral artery disease. Valsartan (VAL), an angiotensin receptor blocker drug for hypertension, has been limited due to its poor solubility and poor absorption from the GIT, which leads to low oral bioavailability. Objectives/Method: In the present research, firstly, VAL-loaded nanoliposomes were formulated and optimized using the Box–Behnken design (BBD). Optimized VAL-nanoliposomes were physically characterized and their fate was examined by scanning and transmission microscopy, DSC, FTIR, XRD, and ex vivo studies using rat skin. In vitro studies using human keratinocyte (HaCaT) cells showed a decrease in cell viability as the liposome concentration increased. Secondly, the formulation of VAL-loaded nanoliposomes was integrated into dissolvable microneedles (DMNs) to deliver the VAL transdermally, crossing the skin barrier for better systemic delivery. Results: The optimized nanoliposomes showed a vesicle size of 150.23 (0.47) nm, a ZP of −23.37 (0.50) mV, and an EE% of 94.72 (0.44)%. The DMNs were fabricated using a ratio of biodegradable polymers, sodium alginate (SA), and hydroxypropyl methylcellulose (HPMC). The resulting VAL-LP-DMNs exhibited sharp pyramidal microneedles, adequate mechanical properties, effective skin insertion capability, and rapid dissolution of the microneedles in rat skin. In the ex vivo analysis, the transdermal flux of VAL was significantly (5.36 (0.39) μg/cm2/h) improved by VAL-LP-DMNs. The enhancement ratio of the VAL-LP-DMNs was 1.85. In conclusion, liposomes combined with DMNs have shown high potential and bright prospects as carriers for the transdermal delivery of VAL. Conclusions: These DMNs can be explored in studies focused on in vivo evaluations to confirm their safety, pharmacokinetics profile, and pharmacodynamic efficacy.
- 7 April 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (4) , 483
Open AccessDevelopment of Rapidly Dissolving Microneedles Integrated with Valsartan-Loaded Nanoliposomes for Transdermal Drug Delivery: In Vitro and Ex Vivo Evaluation
Background: Hypertension (HTN) is recognized as a major risk factor for cardiovascular disease, chronic kidney disease, and peripheral artery disease. Valsartan (VAL), an angiotensin receptor blocker drug for hypertension, has been limited due to its poor solubility and poor absorption from the GIT, which leads to low oral bioavailability. Objectives/Method: In the present research, firstly, VAL-loaded nanoliposomes were formulated and optimized using the Box–Behnken design (BBD). Optimized VAL-nanoliposomes were physically characterized and their fate was examined by scanning and transmission microscopy, DSC, FTIR, XRD, and ex vivo studies using rat skin. In vitro studies using human keratinocyte (HaCaT) cells showed a decrease in cell viability as the liposome concentration increased. Secondly, the formulation of VAL-loaded nanoliposomes was integrated into dissolvable microneedles (DMNs) to deliver the VAL transdermally, crossing the skin barrier for better systemic delivery. Results: The optimized nanoliposomes showed a vesicle size of 150.23 (0.47) nm, a ZP of −23.37 (0.50) mV, and an EE% of 94.72 (0.44)%. The DMNs were fabricated using a ratio of biodegradable polymers, sodium alginate (SA), and hydroxypropyl methylcellulose (HPMC). The resulting VAL-LP-DMNs exhibited sharp pyramidal microneedles, adequate mechanical properties, effective skin insertion capability, and rapid dissolution of the microneedles in rat skin. In the ex vivo analysis, the transdermal flux of VAL was significantly (5.36 (0.39) μg/cm2/h) improved by VAL-LP-DMNs. The enhancement ratio of the VAL-LP-DMNs was 1.85. In conclusion, liposomes combined with DMNs have shown high potential and bright prospects as carriers for the transdermal delivery of VAL. Conclusions: These DMNs can be explored in studies focused on in vivo evaluations to confirm their safety, pharmacokinetics profile, and pharmacodynamic efficacy.
- Top Cited PapersOpen Access
- 6 January 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (1) , 67
Niosome Preparation Techniques and Structure—An Illustrated Review
A comprehensive review of recent research on niosomes was conducted using a mixed methodology, including searches in databases such as Scopus, PubMed, and Web of Science (WoS). Articles were selected based on relevance. The current review examines the historical development of niosomes focusing on the methods of preparations and the contemporary strategies and prospective advancements within the realm of drug delivery systems, highlighting innovative approaches across transdermal, oral, and cellular delivery. This review reported the method of niosomes preparations including a new and novel approach for the preparation of niosomes known as the ball milling method (BM). This technique allows for the precise manipulation of size and shape, leading to improvements in drug release, encapsulation efficiency, and uniformity compared to traditional methods. Niosomes can serve as carriers for delivering various types of drugs, including hydrophobic, hydrophilic, and amphiphilic. This improves the efficiency of encapsulating different drugs, the size of targeted particles, and the desired zeta potential. This is achieved by using a specific charge-inducing agent for drug delivery and targeting specific diseases. These efforts are crucial for overcoming the current limitations and unlocking the full therapeutic potential of modern medicine.
- 6 January 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (1) , 67
Top Cited PapersOpen AccessNiosome Preparation Techniques and Structure—An Illustrated Review
A comprehensive review of recent research on niosomes was conducted using a mixed methodology, including searches in databases such as Scopus, PubMed, and Web of Science (WoS). Articles were selected based on relevance. The current review examines the historical development of niosomes focusing on the methods of preparations and the contemporary strategies and prospective advancements within the realm of drug delivery systems, highlighting innovative approaches across transdermal, oral, and cellular delivery. This review reported the method of niosomes preparations including a new and novel approach for the preparation of niosomes known as the ball milling method (BM). This technique allows for the precise manipulation of size and shape, leading to improvements in drug release, encapsulation efficiency, and uniformity compared to traditional methods. Niosomes can serve as carriers for delivering various types of drugs, including hydrophobic, hydrophilic, and amphiphilic. This improves the efficiency of encapsulating different drugs, the size of targeted particles, and the desired zeta potential. This is achieved by using a specific charge-inducing agent for drug delivery and targeting specific diseases. These efforts are crucial for overcoming the current limitations and unlocking the full therapeutic potential of modern medicine.
- Open Access
- 25 July 2024
- Published by MDPI AG in Nanomaterials
- Vol. 14 (15) , 1250
Carbon Dots in Photodynamic/Photothermal Antimicrobial Therapy
Antimicrobial resistance (AMR) presents an escalating global challenge as conventional antibiotic treatments become less effective. In response, photodynamic therapy (PDT) and photothermal therapy (PTT) have emerged as promising alternatives. While rooted in ancient practices, these methods have evolved with modern innovations, particularly through the integration of lasers, refining their efficacy. PDT harnesses photosensitizers to generate reactive oxygen species (ROS), which are detrimental to microbial cells, whereas PTT relies on heat to induce cellular damage. The key to their effectiveness lies in the utilization of photosensitizers, especially when integrated into nano- or micron-scale supports, which amplify ROS production and enhance antimicrobial activity. Over the last decade, carbon dots (CDs) have emerged as a highly promising nanomaterial, attracting increasing attention owing to their distinctive properties and versatile applications, including PDT and PTT. They can not only function as photosensitizers, but also synergistically combine with other photosensitizers to enhance overall efficacy. This review explores the recent advancements in CDs, underscoring their significance and potential in reshaping advanced antimicrobial therapeutics.
- 25 July 2024
- Published by MDPI AG in Nanomaterials
- Vol. 14 (15) , 1250
Open AccessCarbon Dots in Photodynamic/Photothermal Antimicrobial Therapy
Antimicrobial resistance (AMR) presents an escalating global challenge as conventional antibiotic treatments become less effective. In response, photodynamic therapy (PDT) and photothermal therapy (PTT) have emerged as promising alternatives. While rooted in ancient practices, these methods have evolved with modern innovations, particularly through the integration of lasers, refining their efficacy. PDT harnesses photosensitizers to generate reactive oxygen species (ROS), which are detrimental to microbial cells, whereas PTT relies on heat to induce cellular damage. The key to their effectiveness lies in the utilization of photosensitizers, especially when integrated into nano- or micron-scale supports, which amplify ROS production and enhance antimicrobial activity. Over the last decade, carbon dots (CDs) have emerged as a highly promising nanomaterial, attracting increasing attention owing to their distinctive properties and versatile applications, including PDT and PTT. They can not only function as photosensitizers, but also synergistically combine with other photosensitizers to enhance overall efficacy. This review explores the recent advancements in CDs, underscoring their significance and potential in reshaping advanced antimicrobial therapeutics.